title: Indirect injury stimulates scar formation-adaptation or pathology?
abstract: In several animal models of osteoarthritis induced by cruciate ligament transection, a dense, scar-like tissue mass forms rapidly on the medial side of the knee joint. This mass mimics clinical fibrosis that sometimes occurs after joint surgery. It is unknown exactly why this medial tissue mass forms and what cells are involved in its formation. This study characterizes this medial mass by histology, biochemistry, and the expression of types I and III collagen mRNA. The medial mass is compared with the medial collateral ligament (MCL) and the MCL epiligament in anterior cruciate-transected and unoperated joints, and to normal skin and skin scar. The morphology of the medial mass resembled the epiligament and skin scar more than the MCL. The concentration of DNA and RNA and the RNA-DNA ratio were elevated dramatically in the medial mass compared with all other tissues including skin scar. However, the mRNA copy number and ratio of collagen types I and III mRNAs did not differ significantly among the medial mass, MCL, epiligament, and skin in either the control or the operated joints. The response of the medial mass, MCL, and MCL epiligament to cruciate transaction involves both hyperplasia and hypertrophy, but without a dramatic shift in cell phenotype. The medial mass may be a useful mimic or model of intraarticular adhesions, hypertrophic scars, ligament sprains, and arthrofibrosis.
authors.affiliation: The McCaig Centre for Joint Injury and Arthritis Research, Department of Cell Biology & Anatomy, University of Calgary, Faculty of Medicine, Calgary, Alberta, Canada.
authors.forename: Jennifer L K
authors.initials: JL
authors.lastname: Matthews
authors.forename: May
authors.initials: M
authors.lastname: Chung
authors.forename: John Robert
authors.initials: JR
authors.lastname: Matyas
mesh_terms: D000222:Adaptation, Physiological; D000818:Animals; D016118:Anterior Cruciate Ligament / Q000737:chemistry / Q000378:metabolism / Q000473:pathology*; D000070598:Anterior Cruciate Ligament Injuries; D002921:Cicatrix / Q000378:metabolism / Q000473:pathology*; D024042:Collagen Type I / Q000235:genetics / Q000378:metabolism; D024061:Collagen Type III / Q000235:genetics / Q000378:metabolism; D004247:DNA / Q000032:analysis; D004195:Disease Models, Animal; D004285:Dogs; D006965:Hyperplasia / Q000378:metabolism / Q000473:pathology; D006984:Hypertrophy / Q000378:metabolism / Q000473:pathology; D017888:Medial Collateral Ligament, Knee / Q000737:chemistry / Q000378:metabolism / Q000473:pathology*; D020370:Osteoarthritis, Knee; D012313:RNA / Q000032:analysis; D012333:RNA, Messenger / Q000378:metabolism; D013264:Stifle / Q000293:injuries / Q000378:metabolism / Q000473:pathology*; D014947:Wounds and Injuries / Q000378:metabolism / Q000473:pathology*
chemical_list: D024042:Collagen Type I; D024061:Collagen Type III; D012333:RNA, Messenger; D012313:RNA; D004247:DNA